miércoles, 7 de octubre de 2026
BuscarExplore
Inteligencia rastreable hasta la fuente

Noticias en las que puede confiar

Cada dato rastreado hasta su fuente, y verificado. Explore las empresas, los datos y las conclusiones detrás de las noticias.

Lo que estamos viendo

Conclusiones que nuestra IA extrae de los datos rastreados — léalas como interpretación, cada una respaldada por los datos y las entidades que menciona.

transformation· bullish

Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs

Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.

RentosertibCagriSemaivonescimabRAINFOL-01
transformation· bullish

Enterprise AI Agents Pull Capital and Talent as Big Tech Moves Into the Enterprise Stack

Enterprise software is reorganizing around agentic AI. Funding is flowing to vertical agent startups (Dextr AI, Freehand, Latitude) and AI infrastructure (Groq, Black Forest Labs), while Meta's hire of MongoDB's CEO to lead its new Enterprise Platform signals Big Tech moving directly into the enterprise stack. Incumbents are responding with M&A (Fortinet–Virtue AI) and strong results (UiPath's raised guidance, Alphabet's 82% cloud growth). Investors such as Norwest's Sean Jacobsohn expect finance and ERP software to be disrupted from the edges, while EDB argues that regulated industries need governance enforced by the system rather than left to agents.

Meta Enterprise PlatformDextr AIEnterprise AI Agentic MarketSprinklr, Inc.
transformation· mixed

AI Agents Raise Trust, Identity and Security Stakes as Capital Flows to Fintech Defenses

AI agents are spreading quickly (Rabbit's OS3, Baselayer's Agentic Identity Suite), and this is pushing identity fraud, security and data governance to the front. Baselayer's $35M Series A is the clearest sign that investors are funding trust and identity infrastructure for financial institutions. Frontier labs are meanwhile under pressure over safety, copyright (NYT v. OpenAI/Microsoft) and data acquisition (xAI buying data from failed startups). Hyperscaler spending analysis and state-linked AI hacking show the dual-use risks. The other events, such as the Grindr–PurposeMed deal, executive interviews, insider sales and the WIX class action, are mostly peripheral.

BaselayerJonathan AwadMark ChenowethOpenAI Codex
cycle· mixed

Q3 2026 CFO Turnover and Earnings-Guidance Cycle: Finance Chiefs Steer Through Transitions, Margins and Regulation

Across sectors, finance chiefs are managing a dense autumn 2026 calendar of earnings releases, investor days and executive transitions, including Rivian's CFO leaving for GE Vernova and CFO changes at PJT Partners and Sanofi's executive committee. Their commentary is cautiously constructive. NIKE reports improved gross margin and a restructuring, a regional bank (Donald Hinson's commentary on its merger) says deposit costs have bottomed and merger synergies are on track, and Fair Isaac's Todd Cello holds mortgage guidance. Forward risks include the Durbin Amendment hitting Origin Bancorp in mid-2027, a securities lawsuit deadline, planned debt refinancing and a pending FDA decision on ivonescimab. The AI and fintech link is weak, since the facts are mostly corporate-finance events rather than AI-specific developments.

Dave DentonClaire McDonoughDonald HinsonTodd Cello
transformation· bullish

AI-Driven Oncology: Pipeline Catalysts and Big Pharma's AI Biologics Pivot

Oncology is being reshaped by two converging forces: a dense near-term catalyst calendar (ivonescimab BLA PDUFA date of 2026-11-14, intismeran/personalized mRNA melanoma data at ESMO on 2026-10-24, and combination trials such as ivonescimab plus Datroway in first-line TNBC) and large pharma's shift toward agentic-AI biologics design, led by AstraZeneca's 'lab of the future' with human oversight. Q2 results and guidance (Novocure's record quarter, raised hematology/oncology guidance, ADC Therapeutics' runway into 2028) point to healthy commercial fundamentals, while small-cap biotechs raise capital through deals (Treeline/Standard BioTools) and board appointments (Bicara), and oncology practices add behavioral-health partnerships. The finance angle is mostly indirect: the AI evidence is largely opinion and forecast from a single AstraZeneca source rather than reported financial results, and several unrelated events (Meta trial, rocket recovery, Siemens hacking, Moon study) add no signal.

Datroway (datopotamab deruxtecan)Personalized mRNA Skin Cancer VaccineStage IIB-IV melanomaFirst-line triple-negative breast cancer (TNBC)
trend· bullish

AI Super-Cycle: Memory Boom, Frontier Model Launches, and Rising Governance Scrutiny

AI-driven demand is producing record results and stronger guidance at infrastructure suppliers like Micron, while frontier labs (Anthropic's Claude Opus 5.5, Google's space-based AI chips) keep launching products and AI startups attract most of the growth in jumbo funding rounds. Alongside the boom, concerns are rising about AI capex and legal and regulatory pressure (Alphabet's bull case flags this as its biggest risk) and about concentrated equity and credit exposure to AI. Governance and security are growing as sub-themes: AI agent governance startups, Eve Security's new funding, Pentagon spending on AI lie-detection, and surveillance controversies. Executives such as Jensen Huang downplay existential risk, and the political rebranding of AI as 'super intelligence' echoes Micron's use of the same term.

Micron Technology Inc.AnthropicAlphabet Inc.Jensen Huang
Señales que seguimos
  • EPKINLY Regulatory-Clinical Success Cascade

    High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

  • Satellite-Terrestrial Network Integration Acceleration

    Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases

  • Smart Home AI Platform Convergence

    Samsung will likely announce a unified smart home AI platform or hub within 2-3 months that connects these disparate AI-enabled products

  • AI Integration Acceleration

    Sustained AI feature expansion across Samsung ecosystem in Q1-Q2 2026, with likely follow-up announcements for mobile devices and additional appliances

Hipótesis en estudio
  • NVIDIA GPU acceleration is becoming the dominant infrastructure for AI chip design and EDA workflows, creating a self-reinforcing ecosystem where AI chips are designed using AI-accelerated tools

    88% confidence · sin probar
  • Data center infrastructure investments are shifting from traditional cloud providers to AI-specific facilities, with hyperscalers willing to commit $20B+ multi-year contracts for AI-optimized data center capacity, creating opportunities for specialized infrastructure developers

    88% confidence · sin probar
  • LLM sycophancy is primarily caused by reinforcement learning from human feedback (RLHF) optimization for user approval rather than truthfulness, creating a systematic bias that degrades model reliability in extended conversations

    85% confidence · sin probar
  • AI safety concerns are escalating as models gain access to classified and sensitive data, creating new security vulnerabilities and ethical challenges around training data governance

    85% confidence · sin probar
  • Hyperscaler AI infrastructure investments exceeding $200B combined will drive semiconductor demand and AI chip production capacity expansion in 2026

    85% confidence · sin probar
Sources we've traced
all →
Source document

Intel will help build Elon Musk’s Terafab AI chip factory

“The Verge AI - Consumer Ai Title: Intel will help build Elon Musk’s Terafab AI chip factory Date: 2026-04-07 15:43 Source: https://www.theverge.com/transportation/907976/elon-musk-terafab-intel-ai-chip-spacex-tesla <figure> <img alt="Vector illustration of the Intel logo." src="https://platform.theverge.com/wp-content/…”

Source document

Stock market today: Dow, S&amp;P 500, Nasdaq fall as Wall Street weighs prospects for Iran truce

“Stock market today: Dow, S&P 500, Nasdaq fall as Wall Street weighs prospects for Iran truce US stocks pulled back on Thursday as conflicting messages from the US and Iran fueled mounting uncertainty about the prospects for talks to end the Middle East conflict…”

Source document

Jeffs' Brands: KeepZone AI Enters into Agent Agreement with Skyline Software Systems to Offer 3D Geospatial Visualization Solutions to Global Security Markets

“Jeffs' Brands: KeepZone AI Enters into Agent Agreement with Skyline Software Systems to Offer 3D Geospatial Visualization Solutions to Global Security Markets Tel Aviv, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company…”

Source document

Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026™ Host City in the U.S.

“Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026™ Host City in the U.S. With 75 days to go until the FIFA World Cup 2026™, Visa and partners expand community investment—bringing additional access to sport, education and opportunity to communities across the U.S…”

Source document

Boulder Imaging, ein führender Anbieter von KI-gestützter industrieller Bildverarbeitung, erhält Wachstumsinvestition von Lime Rock New Energy

“Boulder Imaging, ein führender Anbieter von KI-gestützter industrieller Bildverarbeitung, erhält Wachstumsinvestition von Lime Rock New Energy LOUISVILLE, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Boulder Imaging, Inc., ein führender Anbieter von Hochgeschwindigkeits-Bildverarbeitungstechnologien für Windenergie- und F…”

Source document

Truist Cuts CubeSmart (CUBE) Target, Updates REIT Outlook after Q4

“Truist Cuts CubeSmart (CUBE) Target, Updates REIT Outlook after Q4 CubeSmart (NYSE:CUBE) is included among the Dividend Stock Portfolio for Income: 15 Stocks to Invest In.Truist Cuts CubeSmart (CUBE) Target, Updates REIT Outlook after Q4 On March 26, Truist Financial trimmed its price recommendation on CubeSmart (NYSE:…”

Donde las fuentes discrepan
all →
Shopify Inc.

Two different margin values (16% vs 18%) are recorded for the same entity (Shopify Inc.) at the identical timestamp (2026-08-05 00:00:00). With no distinguishing context (same period designation, no qualifier for margin type), these represent conflicting data about the same fact.

Qualcomm Incorporated

Fact B (Q1 2026) and Fact A (Q2 2026) are recorded as observed on the same date: 2026-03-29. This is temporally impossible, since Q2 2026 (April–June) has not yet occurred as of 2026-03-29 (mid-Q1). Financial results for a future period cannot be observed before that period ends. Additionally, 3.7 USD is implausibly low as a cash position for Qualcomm Incorporated, suggesting a data entry error in Fact B.

Citigroup Inc.

Both facts measure EPS for Citigroup with identical observation dates (2025-12-31). FACT A explicitly specifies FY 2025 annual EPS at 6.99 USD/share, while FACT B reports 1.65 USD with an unspecified fiscal period (N/A). The values differ by a factor of ~4.2x, which is too large to explain by rounding, methodology, or data quality variance. While FACT B's 'N/A' fiscal period introduces ambiguity about whether it represents the same annual period, both observations are timestamped identically and purport to measure the same metric on the same date. If both represent FY 2025 annual EPS, this is a direct value conflict. If FACT B represents a different period (e.g., quarterly, TTM, or interim), the ambiguous labeling still constitutes a data quality issue that obscures the reconciliation.

Apple Inc.

The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.

Tesla Inc.

Both facts measure the same attribute (cash) for the same entity (Tesla Inc.) at the same point in time (2025-12-31). Although labeled with different fiscal period categories (FY 2025 vs Q4 2025), both periods end on the same date, making them equivalent time snapshots. The values differ drastically: $16.513 billion vs $44.06 USD. Since Q4 2025 is the final quarter of FY 2025, both should report identical cash balances at period-end. A 375 million-fold magnitude difference indicates a real contradiction, likely caused by a data quality issue (unit error, miscategorization, or source error in FACT B).

ING Group

Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.

Every fact is traceable to the document it came from — see how we source every claim.

Latest News

View All →
El auge de la infraestructura de IA, medido en las cuentas de Micron: el gasto en inversión se duplicó en dos años mientras el consumo y la tecnología especulativa flaquean
Analysis

El auge de la infraestructura de IA, medido en las cuentas de Micron: el gasto en inversión se duplicó en dos años mientras el consumo y la tecnología especulativa flaquean

Las cifras de Micron, verificadas con sus informes ante la SEC, muestran el mayor gasto en inversión de la serie. Mientras tanto, el consumo y la tecnología especulativa se debilitan. Separamos el dato comprobado de la opinión de los analistas e indicamos qué fuentes resistieron la comprobación.

Mientras Nvidia y Meta rechazan frenar la IA, una empresa española demuestra que se puede hacer más con menos chips
Analysis

Mientras Nvidia y Meta rechazan frenar la IA, una empresa española demuestra que se puede hacer más con menos chips

Nvidia y Meta descartan públicamente una desaceleración coordinada de la IA, pero un análisis independiente calcula que el gasto de las grandes tecnológicas necesita una productividad extraordinaria para no perder dinero en 2030. En Guipúzcoa, Multiverse Computing ya muestra una alternativa: comprimir modelos en vez de multiplicar centros de datos.

Maisa AI y el dilema español de la IA agencial: la industria construye infraestructura más rápido de lo que construye confianza
Analysis

Maisa AI y el dilema español de la IA agencial: la industria construye infraestructura más rápido de lo que construye confianza

Mientras el coste de producción de Nvidia casi se cuadruplicó en dos años y Manulife, Box y Microsoft firman nuevos pactos de gobernanza, una encuesta citada por el sector —que nuestro sistema solo pudo verificar en 0 de 11 afirmaciones comprobables— sugiere que la confianza en los agentes de IA no crece al mismo ritmo que el hardware que los sostiene.

Una empresa española redefine la eficiencia en IA el mismo día en que Wall Street castiga a Palantir pese a un contrato récord del Ejército de EE. UU.
Analysis

Una empresa española redefine la eficiencia en IA el mismo día en que Wall Street castiga a Palantir pese a un contrato récord del Ejército de EE. UU.

Multiverse Computing, con sede en San Sebastián, presenta datos verificados de modelos de IA comprimidos con el doble de rendimiento en chips estándar. El mismo día en que Palantir gana el contrato TITAN del Ejército y suma un nuevo directivo, su acción cae un 6%: el dinero privado de IA sigue disparado, pero el mercado público empieza a exigir pruebas, no solo anuncios.

El auge de los chips de IA financiariza el sector: Nvidia propone titulizar GPU por 500.000 millones mientras Micron dispara su inversión
Analysis

El auge de los chips de IA financiariza el sector: Nvidia propone titulizar GPU por 500.000 millones mientras Micron dispara su inversión

Nvidia propone un mercado de 500.000 millones de dólares respaldado por GPU, Washington entra en el capital de GlobalFoundries y Micron casi duplica su inversión en dos años, según datos verificados ante la SEC. Via News examina qué está confirmado, qué es aún una propuesta, y por qué un ETF apalancado del sector cayó un 17% en un solo día.

Nvidia propone titulizar chips por 500.000 millones de dólares mientras Washington financia a GlobalFoundries: el boom de la IA obliga a reinventar cómo se paga el hardware
Analysis

Nvidia propone titulizar chips por 500.000 millones de dólares mientras Washington financia a GlobalFoundries: el boom de la IA obliga a reinventar cómo se paga el hardware

Nvidia plantea empaquetar GPUs como garantía financiera al estilo de las hipotecas, Washington aporta fondos directos a GlobalFoundries y Micron casi duplica su inversión en un año. Via News separa lo verificado en balances de la SEC de lo que aún es solo un anuncio de prensa.

La IA agente entra en la empresa más rápido de lo que la confianza y los datos pueden seguirle el ritmo
Analysis

La IA agente entra en la empresa más rápido de lo que la confianza y los datos pueden seguirle el ritmo

Microsoft, Siemens, Manulife y Box cerraron en julio grandes acuerdos para desplegar agentes de IA en la empresa, mientras un informe advierte que solo la mitad de las organizaciones confía en las decisiones de esos agentes. Via News revisa qué sostienen los datos verificados, qué es análisis propio y dónde la fuente citada falla en sus propias comprobaciones.

Mientras un laboratorio español de IA bate récords de eficiencia, Silicon Valley pierde a otro alto ejecutivo y Google da marcha atrás en sus marcas de agua
Analysis

Mientras un laboratorio español de IA bate récords de eficiencia, Silicon Valley pierde a otro alto ejecutivo y Google da marcha atrás en sus marcas de agua

La española Multiverse Computing logra comprimir modelos de IA con apenas pérdida de precisión, mientras OpenAI pierde a otro directivo clave y Alphabet casi triplica su gasto en infraestructura en dos años. Google, mientras tanto, permite ahora desactivar las marcas de agua que debían dar transparencia a las imágenes generadas por IA.

Mientras OpenAI pierde a otro alto ejecutivo y Google da marcha atrás con sus marcas de agua, una firma española marca el paso en eficiencia de IA
Analysis

Mientras OpenAI pierde a otro alto ejecutivo y Google da marcha atrás con sus marcas de agua, una firma española marca el paso en eficiencia de IA

En San Sebastián, Multiverse Computing logró recortar a la mitad el tiempo de procesamiento de un modelo Llama comprimido. Casi al mismo tiempo, Google empezó a permitir quitar las marcas de agua de sus imágenes de IA y OpenAI perdió a otro ejecutivo clave: la industria habla de transparencia mientras sus movimientos apuntan en direcciones distintas.

La fiebre de los chips de IA se enfría en Wall Street: qué significa para los inversores hispanohablantes cuando ni un solo protagonista del expediente es de habla hispana
Analysis

La fiebre de los chips de IA se enfría en Wall Street: qué significa para los inversores hispanohablantes cuando ni un solo protagonista del expediente es de habla hispana

SK hynix amplía su alianza con Nvidia y Washington entra en el capital de GlobalFoundries, pero las acciones de semiconductores sufrieron una fuerte corrección en julio. El expediente verificado no registra ninguna empresa española o latinoamericana entre los protagonistas: la exposición para esos mercados llega por la vía indirecta de ETFs globales y cadenas de suministro.

Western Union adquiere Lana México junto con Intermex y Dash en tres compras digitales simultáneas
Consolidación de Remesas

Western Union adquiere Lana México junto con Intermex y Dash en tres compras digitales simultáneas

Western Union ejecutó tres adquisiciones simultáneas —Lana en México, Intermex en Estados Unidos y Dash en Singapur— como parte de una estrategia de expansión digital acelerada. La compra de Lana refuerza su posición en el corredor EE.UU.-México, uno de los de mayor volumen global. El movimiento anticipa escrutinio regulatorio y posibles respuestas de competidores como MoneyGram, Wise y PayPal/Xoom.

Plataformas de trading con IA procesan mil millones de transacciones en mercados emergentes latinoamericanos
Fintech e Innovación

Plataformas de trading con IA procesan mil millones de transacciones en mercados emergentes latinoamericanos

Finance Pilot lanzó capacidades de trading automatizado impulsadas por IA con optimización de latencia en servidores en la nube. Pelican procesó más de mil millones de transacciones a través de múltiples estándares bancarios globales. MercadoLibre invierte fuertemente en herramientas de IA agéntica para expandir servicios financieros digitales.

Hecho también para máquinas

Cada dato aquí es estructurado y rastreado hasta su fuente — para que los sistemas de IA hereden la verdad de base, no afirmaciones reformuladas. Los mismos datos que una persona lee, un modelo puede consultarlos.

Obtenga vía API →
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com